Conjunctival Lymphoma in a Patient on Fingolimod for Relapsing-Remitting Multiple Sclerosis

被引:8
作者
Christopher, Karen L. [1 ]
Elner, Victor M. [1 ]
Demirci, Hakan [1 ]
机构
[1] Univ Michigan, Dept Ophthalmol & Visual Sci, WK Kellogg Eye Ctr, 1000 Wall St, Ann Arbor, MI 48109 USA
关键词
B-CELL LYMPHOMA; RITUXIMAB;
D O I
10.1097/IOP.0000000000000774
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
The authors describe a 39-year-old woman treated with fingolimod for relapsing-remitting multiple sclerosis for 2 years who then developed a bilateral conjunctival mucosa-associated lymphoid tissue lymphoma. Fingolimod treatment for multiple sclerosis has been associated with lymphoma in 3 previously reported cases. This is the first case of ocular adnexal lymphoma presumed to be due to fingolimod. Given that ophthalmologists regularly monitor many patients on fingolimod for fingolimod-associated macular edema and ophthalmic manifestations of multiple sclerosis, the authors hope to alert physicians of the possibility of ocular adnexal lymphoma in these patients.
引用
收藏
页码:E73 / E75
页数:3
相关论文
共 10 条
[1]   Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis [J].
Cohen, Jeffrey A. ;
Barkhof, Frederik ;
Comi, Giancarlo ;
Hartung, Hans-Peter ;
Khatri, Bhupendra O. ;
Montalban, Xavier ;
Pelletier, Jean ;
Capra, Ruggero ;
Gallo, Paolo ;
Izquierdo, Guillermo ;
Tiel-Wilck, Klaus ;
de Vera, Ana ;
Jin, James ;
Stites, Tracy ;
Wu, Stacy ;
Aradhye, Shreeram ;
Kappos, Ludwig .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (05) :402-415
[2]   Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type [J].
Conconi, A ;
Martinelli, G ;
Thiéblemont, C ;
Ferreri, AJM ;
Devizzi, L ;
Peccatori, F ;
Ponzoni, M ;
Pedrinis, E ;
Dell'Oro, S ;
Pruneri, G ;
Filipazzi, V ;
Dietrich, PY ;
Gianni, AM ;
Coiffier, B ;
Cavalli, F ;
Zucca, E .
BLOOD, 2003, 102 (08) :2741-2745
[3]   Sphingosine-1-Phosphate and Lymphocyte Egress from Lymphoid Organs [J].
Cyster, Jason G. ;
Schwab, Susan R. .
ANNUAL REVIEW OF IMMUNOLOGY, VOL 30, 2012, 30 :69-94
[4]   B-cell depletion with Rituximab in relapsing-remitting multiple sclerosis [J].
Hauser, Stephen L. ;
Waubant, Emmanuelle ;
Arnold, Douglas L. ;
Vollmer, Timothy ;
Antel, Jack ;
Fox, Robert J. ;
Bar-Or, Amit ;
Panzara, Michael ;
Sarkar, Neena ;
Agarwal, Sunil ;
Langer-Gould, Annette ;
Smith, Craig H. .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (07) :676-688
[5]   Fingolimod (FTY720) therapy in Japanese patients with relapsing multiple sclerosis over 12 months: results of a phase 2 observational extension [J].
Kira, Jun-ichi ;
Itoyama, Yasuto ;
Kikuchi, Seiji ;
Hao, Qi ;
Kurosawa, Takayoshi ;
Nagato, Kazuo ;
Tsumiyama, Isao ;
von Rosenstiel, Philipp ;
Zhang-Auberson, Lixin ;
Saida, Takahiko .
BMC NEUROLOGY, 2014, 14
[6]   Malignant lymphoma of the conjunctiva [J].
Kirkegaard, Marina M. ;
Coupland, Sarah E. ;
Prause, Jan U. ;
Heegaard, Steffen .
SURVEY OF OPHTHALMOLOGY, 2015, 60 (05) :444-458
[7]   FTY720 demonstrates promising preclinical activity for chronic lymphocytic leukemia and lymphoblastic leukemia/lymphoma [J].
Liu, Qing ;
Zhao, Xiaobin ;
Frissora, Frank ;
Ma, Yihui ;
Santhanam, Ramasamy ;
Jarjoura, David ;
Lehman, Amy ;
Perrotti, Danilo ;
Chen, Ching-Shih ;
Dalton, James T. ;
Muthusamy, Natarajan ;
Byrd, John C. .
BLOOD, 2008, 111 (01) :275-284
[8]   Fingolimod blocks immunosurveillance of myeloma and B-cell lymphoma resulting in cancer development in mice [J].
Lorvik, Kristina Berg ;
Bogen, Bjarne ;
Corthay, Alexandre .
BLOOD, 2012, 119 (09) :2176-2177
[9]   Lymphomatoid papulosis type D in a fingolimod-treated multiple sclerosis patient [J].
Matoula, Theoni ;
Nikolaou, Vasiliki ;
Marinos, Leonidas ;
Katsavos, Serafeim ;
Nasis, George ;
Economidi, Afroditi ;
Karampidou, Konstantina ;
Stratigos, Alexander ;
Antoniou, Christina .
MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (12) :1630-1631
[10]   Lymphomatoid papulosis: A cutaneous lymphoproliferative disorder in a patient on fingolimod for multiple sclerosis [J].
Samaraweera, Amal P. R. ;
Cohen, Stuart N. ;
Akay, Ela M. ;
Evangelou, Nikos .
MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (01) :122-124